Effect of Danofloxacin Treatment on the Development of Fluoroquinolone Resistance in <i>Campylobacter jejuni</i> in Calves

Effect of Danofloxacin Treatment on the Development of Fluoroquinolone Resistance in <i>Campylobacter jejuni</i> in Calves

<i>Campylobacter</i> is a leading cause of foodborne gastroenteritis. Recent studies have indicated a rise in fluoroquinolone-resistant (FQ-R) <i>Campylobacter</i> in cattle, where FQ is used to control bovine respiratory disease (BRD). To assess the effect of danofloxacin tr...

Full description

Bibliographic Details
Main Authors:	Debora Brito Goulart, Ashenafi Feyisa Beyi, Zuowei Wu, Mehmet Cemal Adiguzel, Anastasia Schroeder, Kritika Singh, Changyun Xu, Melda Meral Ocal, Renee Dewell, Grant A. Dewell, Paul J. Plummer, Qijing Zhang, Orhan Sahin
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Antibiotics
Subjects:	<i>Campylobacter</i> cattle colonization rectal feces bovine respiratory disease (BRD) fluoroquinolone/danofloxacin treatment
Online Access:	https://www.mdpi.com/2079-6382/11/4/531

Similar Items

Influence of Single Dose Enrofloxacin Injection on Development of Fluoroquinolone Resistance in <i>Campylobacter jejuni</i> in Calves
by: Debora Brito Goulart, et al.
Published: (2022-10-01)

Danofloxacin Treatment Alters the Diversity and Resistome Profile of Gut Microbiota in Calves
by: Ashenafi Feyisa Beyi, et al.
Published: (2021-09-01)

Distribution of CRISPR Types in Fluoroquinolone-Resistant <i>Campylobacter jejuni</i> Isolates
by: Mehmet Cemal Adiguzel, et al.
Published: (2021-03-01)

The Effect of Danofloxacine on in vitro Rat Myometrium
by: Yaşar Akar, Haki Kara1*, Kadir Servi2, Hamit Yildiz3
Published: (2010-10-01)

Spectrofluorimetric determination of cefixime using terbium-danofloxacin probe
by: Jamshid L Manzoori, et al.
Published: (2014-04-01)

A Homologous Bacterin Protects Sheep against Abortion Induced by a Hypervirulent <i>Campylobacter jejuni</i> Clone
by: Zuowei Wu, et al.
Published: (2020-11-01)

Technetium-labeled danofloxacin complex as a model for infection imaging
by: Moustapha Eid Moustapha, et al.
Published: (2016-11-01)

Antimicrobial activity of danofloxacin regarding to bacteria, pathogens of respiratory infections in pigs
by: T. I. Stetsko, et al.
Published: (2019-11-01)

Removal of danofloxacin and ofloxacin as different generations of fluoroquinolones from aqueous solutions through the adsorption process using granular activated carbon: A comparative study, mechanism elucidation, and applicability investigation
by: Maram Ashraf, et al.
Published: (2023-05-01)

Efficiency of danofloxacin in treatment of pig colibacteriosis
by: T. I. Stetsko
Published: (2020-07-01)

Susceptibility breakpoint for Danofloxacin against swine Escherichia coli
by: Yuqi Yang, et al.
Published: (2019-02-01)

Pharmacokinetics of Danofloxacin in Gushi Chickens after Single Oral and Intravenous Administration
by: Jun-Cheng Chen, et al.
Published: (2023-08-01)

Electroanalytical Determination of Danofloxacin in Biological Samples Using Square Wave Voltammetry
by: Chirley Vanessa Boone, et al.
Published: (2014-10-01)

Flaxseed-enriched diets change milk concentration of the antimicrobial danofloxacin in sheep
by: Jon Andoni Otero, et al.
Published: (2018-01-01)

Development of novel ELISA based on tyramine signal amplification for sensitive detection of danofloxacin
by: BAO Huanhuan, et al.
Published: (2022-05-01)

Enrofloxacin Alters Fecal Microbiota and Resistome Irrespective of Its Dose in Calves
by: Ashenafi Feyisa Beyi, et al.
Published: (2021-10-01)

Pharmacokinetic Behavior and Pharmacokinetic/Pharmacodynamic Integration of Danofloxacin Following Single or Co-Administration with Meloxicam in Healthy Lambs and Lambs with Respiratory Infections
by: Mehmet Nihat Ural, et al.
Published: (2021-09-01)

In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Danofloxacin in Rabbits Infected With Salmonella typhimurium After Oral Administration
by: Xia Xiao, et al.
Published: (2018-04-01)

The PK–PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model
by: Nan Zhang, et al.
Published: (2017-05-01)

Exploration of Clinical Breakpoint of Danofloxacin for <i>Glaesserella parasuis</i> in Plasma and in PELF
by: Zihui Xu, et al.
Published: (2021-07-01)

Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against Pasteurella multocida and Haemophilus parasuis in Piglets
by: Yu-Feng Zhou, et al.
Published: (2022-02-01)

Rational Use of Danofloxacin for Treatment of <i>Mycoplasma gallisepticum</i> in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift
by: Shuge Wang, et al.
Published: (2022-03-01)

Population Pharmacokinetics of Danofloxacin in Yellow River Carp (Cyprinus carpio haematopterus) After One Single Oral Dose
by: Zhe-Wen Song, et al.
Published: (2022-04-01)

Pharmacokinetic/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of Actinobacillus pleuropneumoniae After Repeated Administration of Danofloxacin
by: Longfei Zhang, et al.
Published: (2018-10-01)

In vitro antibacterial activity of danofloxacin against Escherichia coli in Gushi chickens and its residue depletion following multiple oral administration
by: Jun-Cheng Chen, et al.
Published: (2024-04-01)

Growth kinetics and fitness of fluoroquinolone resistant and susceptible Campylobacter jejuni strains of cattle origin
by: Debora Brito Goulart, et al.
Published: (2023-04-01)

Pharmacokinetics of tulathromycin in pregnant ewes (Ovis aries) challenged with Campylobacter jejuni.
by: Michael Yaeger, et al.
Published: (2021-01-01)

Fecal Microbiota Transplantation Reduces <i>Campylobacter jejuni</i> Colonization in Young Broiler Chickens Challenged by Oral Gavage but Not by Seeder Birds
by: Jinji Pang, et al.
Published: (2023-10-01)

Prevalence of Beta-Lactam and Quinolone/Fluoroquinolone Resistance in Enterobacteriaceae From Dogs in France and Spain—Characterization of ESBL/pAmpC Isolates, Genes, and Conjugative Plasmids
by: Véronique Dupouy, et al.
Published: (2019-08-01)

Development of Fluoroquinolone Resistance through Antibiotic Tolerance in Campylobacter jejuni
by: Myungseo Park, et al.
Published: (2022-10-01)

A fluoroquinolone resistance associated mutation in gyrA affects DNA supercoiling in Campylobacter jejuni
by: Jing eHan, et al.
Published: (2012-03-01)

Synergistic anti-Campylobacter jejuni activity of fluoroquinolone and macrolide antibiotics with phenolic compounds
by: Euna eOh, et al.
Published: (2015-10-01)

Fluoroquinolone Analogs, SAR Analysis, and the Antimicrobial Evaluation of 7-Benzimidazol-1-yl-fluoroquinolone in In Vitro, In Silico, and In Vivo Models
by: Mitzzy Fátima Medellín-Luna, et al.
Published: (2023-08-01)

Increasing Fluoroquinolone Resistance in Campylobacter jejuni, Pennsylvania, USA,1982–20011
by: Irving Nachamkin, et al.
Published: (2002-12-01)

Detection and Prevalence of Macrolide and Fluoroquinolone Resistance in <i>Mycoplasma genitalium</i> in Badalona, Spain
by: Belén Rivaya, et al.
Published: (2022-04-01)

Antimicrobial Susceptibility Testing for Escherichia coli Strains to Fluoroquinolones, in Urinary Tract Infections
by: FA Nakhjavani, et al.
Published: (2007-05-01)

Antimicrobial Susceptibility Testing for Escherichia coli Strains to Fluoroquinolones, in Urinary Tract Infections
by: FA Nakhjavani, et al.
Published: (2007-03-01)

Fluoroquinolones-Associated Disability: It Is Not All in Your Head
by: Maya Z. Freeman, et al.
Published: (2021-07-01)

The Role of Bromodomain Testis-Specific Factor, BRDT, in Cancer: A Biomarker and A Possible Therapeutic Target
by: Ekaterina Flin, et al.
Published: (2017-05-01)

To compare the in vitro activity of 3 popular fluoroquinolones against common respiratory and middle ear pathogens
by: Soma Sarkar, et al.
Published: (2013-12-01)